Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;41(7):1647-1650.
doi: 10.1007/s10072-020-04519-x. Epub 2020 Jul 2.

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study

Gloria Dalla Costa  1   2 , Letizia Leocani  1   2 , Xavier Montalban  3 , Ana Isabel Guerrero  3 , Per Soelberg Sørensen  4 , Melinda Magyari  4 , Richard J B Dobson  5   6 , Nicholas Cummins  7 , Vaibhav A Narayan  8 , Matthew Hotopf  9 , Giancarlo Comi  10 ; RADAR-CNS consortium
Affiliations

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study

Gloria Dalla Costa et al. Neurol Sci. 2020 Jul.

Abstract

We assessed the prevalence and impact of COVID-19 among multiple sclerosis (MS) patients across Europe by leveraging participant data collected as part of the ongoing EU IMI2 RADAR-CNS major programme aimed at finding new ways of monitoring neurological disorders using wearable devices and smartphone technology. In the present study, 399 patients of RADAR-MS have been included (mean age 43.9 years, 60.7% females) with 87/399 patients (21.8%) reporting major symptoms suggestive of COVID-19. A trend for an increased risk of COVID-19 symptoms under alemtuzumab and cladribine treatments in comparison to injectables was observed. Remote monitoring technologies may support health authorities in monitoring and containing the ongoing pandemic.

Keywords: COVID-19; Multiple Sclerosis; Remote monitoring technologies.

PubMed Disclaimer

Conflict of interest statement

VAN is an employee of Janssen Research & Development LLC and may own equity in the company.

Figures

Fig. 1
Fig. 1
Disease-modifying drugs and risk of suspected COVID-19 infection diagnosis. Gl. acetate glatiramer acetate; DMF, dimethyl fumarate; TRF, teriflunomide; Alem, alemtuzumab; Cladr, cladribine
See this image and copyright information in PMC

References

    1. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi: 10.1038/s41586-020-2012-7. - DOI - PMC - PubMed
    1. Ranjan Y, Rashid Z, Stewart C, et al. RADAR-base: open source mobile health platform for collecting, monitoring, and analyzing data using sensors, wearables, and mobile devices. JMIR Mhealth Uhealth. 2019;7(8):e11734. doi: 10.2196/11734. - DOI - PMC - PubMed
    1. World Health Organization (2020) Surveillance case definitions for human infection with novel coronavirus (nCoV): interim guidance v1, January 2020. World Health Organization. https://apps.who.int/iris/handle/10665/330376. License: CC BY-NC-SA 3.0 IGO. Accessed 1 Jul 2020
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Firth D. Bias reduction of maximum likelihood estimates. Biometrika [Internet]. 1993;80(1):27–38. doi: 10.1093/biomet/80.1.27. - DOI